Clinical Trial

Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection

Name: Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection — clinical trial record (NCT07493824)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The effectiveness of Patellin ® antibacterial solution in treating persistent cervical HR-HPV infection

Trial Details

NCT Number	NCT07493824
Lead Sponsor	The First Hospital of Jilin University
Conditions	Persistent HR-HPV Infection of the Cervix
Enrollment	115 participants
Start Date	2025-07-24
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-25